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Abstract
Background: Mucopolysaccharidoses (MPS) is a group of hereditary
multisystemic lysosomal disorders. Most neuroimaging studies in MPS have
focused on the supratentorial compartment and craniocervical junction abnor-
malities, and data regarding posterior fossa findings are scarce in the literature.
Thus, our purpose is to describe posterior fossa findings on magnetic resonance
imaging (MRI) of MPS patients.
Methods: We reviewed routine MRI scans of MPS patients being followed up at
our institution (types I, II, III, IV, and VI), focusing on posterior fossa structures.
Results: Forty-seven MPS patients were included. MRI-visible perivascular
spaces were commonly found in the midbrain and adjacent to the dentate
nuclei (85% and 55% of patients, respectively). White-matter lesion was not
identified in most cases. Its most frequent localizations were in the pons and
cerebellum (34% and 30% of patients, respectively). Enlargement of cerebrospi-
nal fluid (CSF) spaces in the posterior fossa was present in 55% of individuals
and was more frequent in neuronopathic patients (73% vs 40%; P = .02). Cere-
bellar volume was classified as normal, apparent macrocerebellum, atrophic,
and hypoplastic in 38%, 38%, 21%, and 3% of patients, respectively. A depres-
sion of the posterior fossa floor in the midline sagittal plane was found in
22 patients (47%), which was statistical significantly associated with enlarge-
ment of CSF spaces (P = .02) and with apparent macrocerebellum (P = .03).
Conclusion: The present study compiled the main posterior fossa findings in
MPS patients. Classically described in the supratentorial compartment, MRI-
visible perivascular spaces, white matter lesions, and enlarged perivascular spaces
were also found in the posterior fossa. However, atrophy, which commonly affects
cerebral hemispheres, was not the most frequent cerebellar morphology found in
our study. Moreover, potential findings for future research were described.
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1 | BACKGROUND
Mucopolysaccharidoses (MPS) is a group of hereditary
lysosomal disorders with an estimated incidence of 1 per
25 000 individuals.1 InMPS, genetic variants lead to deficiency
in lysosomal enzymes, which are involved in the degradation
of glycosaminoglycans leading to accumulation of these par-
tially degraded macromolecules within lysosomes and in the
extracellular space, culminating in cell dysfunction of several
organs and body tissues. According to the deficient lysosomal
enzyme, MPS are classified into seven types (I, II, III, IV, VI,
VII, and IX).Most of themare inherited inanautosomal reces-
sive pattern, except for type II, which is an X-linked disease.2
Clinically, MPS are multisystem, heterogeneous disorders,
withvaryclinicalpresentationsandseverity.3
Individuals with MPS I, II, III, VII, and IX might present
with neurological impairment. However, even the individuals
with the non-neuropathic forms might have brain abnormali-
ties. Magnetic resonance imaging (MRI) is the modality of
choice for neuraxial evaluation in MPS, as in other hereditary
metabolic diseases.4 White matter lesions, cortical atrophy,
hydrocephalus, enlarged perivascular spaces, and stenosis of
the craniocervical junction are the main imaging findings
described in this population. These abnormalities occur in dif-
ferentcombinationsandseverities, even in individualswith the
same MPS type.5-7 Most neuroimaging studies in MPS have
focused on the supratentorial compartment and craniocervical
junction.4,8-11 Studies specifically describing posterior fossa
findings in these patients are scarce. White matter lesions and
enlarged perivascular spaces have been described in the
brainstem and cerebellum. Abnormal cerebellar volume
(hypoplasia and macrocerebellum), mega cisterna magna,
arachnoid cyst, and Chiari I malformation are other reported
findings.12-15
Within this context, this study aims to describe the
findings observed in routine brain MRI studies of patients
with MPS, focusing on posterior fossa structures.
2 | MATERIAL AND METHODS
2.1 | Study design and participants
The study was approved by the Ethics Committee of our
Hospital de Clínicas de Porto Alegre, Brazil. The cohort
is composed of patients with MPS who are followed in
the Medical Genetics Service at our institution. Informed
consent was obtained from all subjects or legal guardian.
All methods were carried out in accordance with relevant
guidelines and regulations.
This cross-sectional study included all patients with
confirmed MPS followed at our institution who had under-
gone routine brain MRI, usually performed at the begin-
ning of outpatient follow-up, from October 2012 to the
time of writing. The inclusion criteria were: (a) confirmed
diagnosis of MPS by enzyme assay and/or DNA testing,
including all MPS types, with no age restriction (adult and
pediatric patients); and (b) available brain MRI on picture
archiving system, including at least axial fluid-attenuated
inversion recovery (FLAIR) and T2-weighted images and
three-dimensional T1-weighted images. Patients for whom
brain MRI was not available on picture archiving system
were excluded. All MRI studies were performed in a 1.5T
scanner (Achieva, Philips, Best, Netherlands).
2.2 | Image analysis and variables of
interest
Two experienced neuroradiologists evaluated the images
by consensus. The following variables were analyzed in
the posterior fossa:
2.2.1 | MRI-visible perivascular spaces
Defined as cystic structures isointense to cerebrospinal fluid
(CSF) in all pulse sequences. MRI-visible perivascular spaces
were classified as absent or present. If present, the maximum
axial diameter was measured and the location was described
(midbrain, pons, medulla, and/or cerebellum).
2.2.2 | White matter lesions
Characterized by focal or confluent T2-FLAIR hyperintense,
T1-hypointense lesions in white matter areas. Presence and
location were described.
2.2.3 | Cerebellar volume
The cerebellar volume was evaluated qualitatively on sagit-
tal and axial images and classified as normal, atrophic
(enlarged cerebellar sulci), hypoplastic (reduced cerebellar
dimensions, but preserved morphology), or apparent
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macrocerebellum (increased cerebellar dimensions with
reduction or absence of pericerebellar CSF), following a pre-
viouslydescribedmodel forMPSpatients.12
2.2.4 | Middle cerebellar peduncles
width
The evaluators subjectively perceived a thickened aspect of the
middle cerebellar peduncles (MCPs) in several patients. This
finding has not been described previously in patients with
MPS, and, to our knowledge, there is no standardized mea-
surement for these structures. Thenwe decided to use as refer-
ence the measurement method described in an article that
evaluated MCP width in patients with multiple system atro-
phy, Parkinson disease, and control subjects.16 Right and left
MCPs were identified on parasagittal view and the distance
between their superior and inferior borders was measured
(Figure1A).Thelargest laterolateraldiameterofMCPsonaxial
slices, perpendicular to their anteroposterior axis, was also
measured (Figure 1B). Right and left MCPs were measured
separately, andameanvalue forbothMCPswascalculated.
2.2.5 | Posterior fossa shape
Some patients in our series were found to have a hook-
shaped depression of the posterior fossa floor in the midline
sagittal plane (Figure 2). To the best of our knowledge, there
is no previous description of this finding in the literature. We
denominated this morphologic alteration “inverted J-shaped
posterior fossa,” and it was classified as absent or present.
2.2.6 | Enlargement of CSF spaces
Originally, we intended to assess the presence of mega cis-
terna magna and arachnoid cyst individually. However, the
evaluators realized it was not possible to clearly distinguish
between these two entities in several patients, due to their
small size and similar location. Thus, mega cisterna magna
and arachnoid cyst were clustered into one category:
enlargement of CSF spaces. This was classified as absent or
present, and, if present, bilateral or unilateral.
2.2.7 | Chiari malformation
Caudal descent of the cerebellar tonsils and brain stem
through the foramen magnum was also recorded as absent
or present.
In addition to the evaluation of brain MRI, clinical
data (MPS type, gender, and age at MRI scan) were col-
lected from all included patients.
2.3 | Statistical methods
Variables were described for the whole population of
patients and for each MPS type group separately. Due to
FIGURE 1 A, Sagittal T1-weighted volumetric acquisition demonstrating measurement of middle cerebellar peduncle width (distance
between its superior and inferior borders). B, Axial T1-weighted volumetric acquisition demonstrating measurement of middle cerebellar
peduncle width, perpendicular to its anteroposterior axis
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the wide age variation among patients, this parameter
was presented as a range between the youngest and the
oldest individuals. Other continuous variables were
described as mean and SD. All categorical variables were
presented as absolute and relative (percentage) frequen-
cies. Chi-square test and t test were used to compare cate-
gorical and continuous variables, respectively.
3 | RESULTS
3.1 | Patients
Forty-seven MPS patients (29 males and 18 females) met
the inclusion criteria and were enrolled in the present
study. In this population, there were 13 patients with
MPS type I, 15 with MPS type II, 6 with MPS type III,
10 with MPS type IV, and 3 with MPS type VI. There
were no cases of MPS type VII or IX. The age of the
patients at the time of brain MRI scan ranged from 0.8 to
36.9 years. These descriptive data and MPS subtypes are
summarized in Table 1.
3.2 | Main findings
The results of posterior fossa MRI analysis are described
in Table 2, according to the types of MPS. Due to the
wide clinical variation, we also compare neuronopathic
(MPS types I Hurler, IIA, and III) and mild neu-
ronopathic/non-neuronopathic (MPS types I Hurler-
Scheie, I Scheie, IIB, IV, and VI) MPS patients (Table 3).
MRI-visible perivascular spaces were commonly
found in the cerebral peduncles (present in 85% of indi-
viduals) (Figure 3A). The white matter adjacent to the
dentate nuclei was the second most common localization
(present in 55% of patients) (Figure 3B). Pons and
medulla were less commonly affected (21% and 8% of
individuals, respectively). The mean maximum axial
diameter was 0.24 cm (SD ± 0.06 cm).
White matter lesions were most frequently identified
in the pons and cerebellum (34% and 30% of patients,
respectively) (Figure 4). Only two individuals (4%) had
mild lesions in the midbrain. No case of medullary
involvement was identified.
There was no statistically significant difference between
neuronopathic and mild neuronopathic/non-neuronopathic
MPS patients regarding presence and distribution of MRI-
visible perivascular spaces and white matter lesions.
Enlargement of CSF spaces in the posterior fossa was
present in 26 individuals (55%), being bilateral in 22 patients
(Figure 5). All four cases of unilateral enlargement of CSF
spaces were located on the left. In all cases, the enlargement
of CSF spaces was situated inferomedially to the cerebellar
hemispheres, next to the midline. This finding was present
in 16 neuronopathic patients (73%) and only in 10 mild
neuronopathic/non-neuronopathic patients (40%), with a
statistically significant difference (P = .02).
Cerebellar volume was classified as normal in 18 patients
(38%). Cerebellar atrophy was present in 10 patients (21%).
Apparent macrocerebellum also was identified in 17% to
67% of patients according to MPS type. Hypoplastic cerebel-
lum was found in only one individual (3%). There was no
statistically significant difference between neuronopathic
and mild neuronopathic/non-neuronopathic MPS patients
regarding cerebellar volume frequencies. Illustrative exam-
ples of each cerebellum category are shown in Figure 6.
As mentioned previously, during analysis of brain
images, the evaluators subjectively perceived a thickened
aspect of the MCP in several individuals. Since this finding
has not been previously described in patients with MPS and
there is no standardized measurement of these structures,
we measured MCPs in the sagittal plane based on a previ-
ous study16 (Figure 1A), which described a mean sagittal
MCP width of 0.98 cm (SD ± 0.07 cm) in 14 control sub-
jects with a mean age of 66.9 years (SD ± 6.5 years). In the
present study, width measurement was also performed in
the axial plane to provide a reference for future studies
(Figure 1B). The mean MCP widths in the sagittal and axial
planes in our MPS patients were 1.17 cm (SD ± 0.17 cm)
and 1.66 cm (SD ± 0.17 cm), respectively. For both sagittal
FIGURE 2 MPS IIA in a 7-year-old boy. Sagittal T1-weighted
volumetric acquisition showing depression of the posterior fossa
floor in the midline sagittal plane (arrow), a previously undescribed
abnormality we termed “inverted J-shaped posterior fossa.” MPS,
mucopolysaccharidoses
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Not applicable Not applicable
Male sex (n) 7 (54%) 15 (100%) 3 (50%) 2 (20%) 2 (67%) 29 (62%)
Age range in years
(minimum-maximum)
1-36.9 1.9-34.4 2.8-15.2 0.8-30.7 15.3-21.1 0.8-36.9
Abbreviations: MPS, mucopolysaccharidosis; n, number of individuals.















Midbrain (n) 10 (77%) 14 (93%) 6 (100%) 7 (70%) 3 (100%) 40 (85%)
Pons (n) 3 (23%) 5 (33%) 1 (17%) 0 1 (33%) 10 (21%)
Medulla (n) 1 (8%) 3 (20%) 0 0 0 4 (8%)
Cerebellum (n) 10 (77%) 11 (73%) 0 2 (20%) 3 (100%) 26 (55%)
Mean maximum axial diameter (cm ± SD) 0.24 ± 0.06 0.26 ± 0.05 0.22 ± 0.08 0.19 ± 0.08 0.26 ± 0.05 0.24 ± 0.06
White matter lesions
Midbrain (n) 0 1 (7%) 1 (17%) 0 0 2 (4%)
Pons (n) 4 (31%) 8 (53%) 1 (17%) 3 (30%) 0 16 (34%)
Medulla (n) 0 0 0 0 0 0
Cerebellum (n) 2 (15%) 6 (40%) 2 (33%) 3 (30%) 1 (33%) 14 (30%)
Cerebellar volume
Normal (n) 4 (31%) 7 (47%) 3 (50%) 4 (40%) 0 18 (38%)
Atrophic (n) 2 (15%) 3 (20%) 2 (33%) 2 (20%) 1 (33%) 10 (21%)
Hypoplastic (n) 0 1 (7%) 0 0 0 1 (3%)
Apparent macrocerebellum (n) 7 (54%) 4 (26%) 1 (17%) 4 (40%) 2 (67%) 18 (38%)
Middle cerebellar peduncle width (sagittal plane)
Right MCP (cm ± SD) 1.18 ± 0.25 1.15 ± 0.16 1.18 ± 0.13 1.15 ± 0.18 1.30 ± 0.10 1.17 ± 0.18
Left MCP (cm ± SD) 1.21 ± 0.22 1.18 ± 0.15 1.20 ± 0.09 1.16 ± 0.17 1.33 ± 0.06 1.20 ± 0.17
Mean (cm ± SD) 1.20 ± 0.23 1.17 ± 0.15 1.19 ± 0.11 1.15 ± 0.17 1.32 ± 0.08 1.17 ± 0.17
Middle cerebellar peduncle width (axial plane)
Right MCP (cm ± SD) 1.61 ± 0.14 1.65 ± 0.17 1.55 ± 0.23 1.73 ± 0.18 1.90 ± 0.20 1.66 ± 0.19
Left MCP (cm ± SD) 1.60 ± 0.13 1.67 ± 0.17 1.53 ± 0.19 1.72 ± 0.15 1.87 ± 0.15 1.65 ± 0.17
Mean (cm ± SD) 1.61 ± 0.13 1.66 ± 0.17 1.54 ± 0.20 1.72 ± 0.16 1.88 ± 0.18 1.66 ± 0.17
Posterior fossa shape
Inverted J-shaped posterior fossa (n) 5 (38%) 10 (67%) 1 (17%) 4 (40%) 2 (67%) 22 (47%)
Enlargement of CSF spaces
Absent (n) 6 (46%) 2 (13%) 2 (33%) 9 (90%) 2 (67%) 21 (45%)
Bilateral (n) 4 (31%) 13 (87%) 3 (50%) 1 (10%) 1 (33%) 22 (47%)
Unilateral (n) 3 (23%) 0 1 (17%) 0 0 4 (8%)
Abbreviations: CSF, cerebrospinal fluid; MCP, middle cerebellar peduncle; MPS, mucopolysaccharidosis; MRI, magnetic resonance imaging; n, number of
individuals.
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and axial MCP width, there was no statistically significant
difference between neuronopathic and mild neuronopathic/
non-neuronopathic MPS patients.
Regarding posterior fossa shape, a depression of the
posterior fossa floor in the midline sagittal plane, which
we termed the “inverted J-shaped posterior fossa,” was
found in 22 patients (47%) (Figure 2), without statistically
significant difference between neuronopathic and mild
neuronopathic/non-neuronopathic MPS patients.
There was no case of Chiari malformation in the
study population.
3.3 | Other analyses
Inverted J-shaped posterior fossa was statistical signifi-
cantly associated with enlargement of CSF spaces
(P = .02) and with the presence of apparent mac-
rocerebellum (P = .03). The results are shown in Table 4.
4 | DISCUSSION
Since most neuroimaging studies in MPS patients have
focused on supratentorial findings, this study aimed to
analyze and compile the main posterior fossa findings in
this population. We included 47 patients with MPS
types I, II, III, IV, and VI, which represents a relatively
large sample, given the rarity of this condition. In
summary, we found that MRI-visible perivascular
spaces and white matter lesions also occur in the pos-
terior fossa. The former was usually small and located
in the cerebral peduncles or adjacent to the dentate
nuclei. The latter occurred more commonly in the




and III) n = 22
Mild neuronopathic/
non-neuronopathic MPS
patients (IHS, IS, IV,
and VI) n = 25 P value
Male sex (n) 16 (73%) 13 (52%) .14a
Age (y) (mean ± SD) 7.37 ± 4.62 19.26 ± 9.84 .001b
MRI-visible perivascular spaces
Midbrain (n) 21 (95%) 19 (76%) .06a
Pons (n) 6 (27%) 4 (16%) .35a
Medulla (n) 3 (14%) 1 (4%) .24a
Cerebellum (n) 11 (50%) 15 (60%) .49a
White matter lesions
Midbrain (n) 1 (4%) 1 (4%) .93a
Pons (n) 9 (41%) 7 (28%) .35a
Medulla (n) 0 (%) 0 (0%) 1a
Cerebellum (n) 8 (36%) 6 (24%) .35a
Enlargement of CSF spaces (n) 16 (73%) 10 (40%) .02a
Cerebellar volume
Normal (n) 8 (36%) 10 (40%) .7a
Atrophic (n) 4 (19%) 6 (24%)
Hypoplastic (n) 1 (4%) 0 (0%)
Apparent macrocerebellum (n) 9 (41%) 9 (36%)
Sagittal plane MCP width mean
(mean ± SD)
1.15 ± 0.13 1.21 ± 0.20 .21b
Axial plane MCP width mean (mean ± SD) 1.54 ± 0.13 1.76 ± 0.14 .81b
Inverted J-shaped posterior fossa (n) 10 (45%) 12 (40%) .86a
Abbreviations: CSF, cerebrospinal fluid; IH, I Hurler syndrome; IHS, I Hurler-Scheie syndrome; IS, I Scheie syndrome; MCP, middle cerebellar peduncle; MPS,
mucopolysaccharidosis; MRI, magnetic resonance imaging; n, number of individuals.
aAnalysis performed by Chi-square test for independent samples.
bAnalysis performed by independent t test.
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pons, although more discreetly than usually seen in
the supratentorial compartment.
Atrophy, a commonly described finding in the cere-
bral hemispheres of patients with MPS,5 was not the most
frequent cerebellar morphology found in the present
study. Approximately three-quarters of the patients had
normal cerebellar volume or apparent macrocerebellum.
The evaluation of the cerebellar volume was evaluated
subjectively, as usually performed in the practice of the
radiologists, and as performed in a previous study with
MPS patients.12 Considering a potential bias related to
subjective evaluation, we opted for a more conservative
denomination (apparent macrocerebellum), since future
volumetric studies are necessary to confirm this finding.
More than half of the patients had enlargement of
CSF spaces in the posterior fossa. This finding was also
FIGURE 3 MPS IIB in a 26-year-old man patient. Axial T2-weighted images show MRI-visible perivascular spaces (A) in the cerebral
peduncles (open arrows) and (B) in the white matter adjacent to the dentate nuclei (arrows). MPS, mucopolysaccharidoses; MRI, magnetic
resonance imaging
FIGURE 4 MPS IIA in a 7-year-old boy. Axial T2-weighted
image shows areas of slight T2-FLAIR hyperintensity in the pons,
characterizing the presence of white matter lesions. FLAIR, fluid-
attenuated inversion recovery; MPS, mucopolysaccharidoses
FIGURE 5 MPS IIA in a 7-year-old boy. Axial T2-weighted
image demonstrates enlargement of CSF spaces in posterior fossa
(asterisks), inferomedially to the cerebellar hemispheres. CSF,
cerebrospinal fluid; MPS, mucopolysaccharidoses
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found in the vast majority of neuronopathic MPS
patients, with a significant difference when compared to
mild neuronopathic/non-neuronopathic MPS patients.
We hypothesized it may reflect a greater impact in CSF
flow in more severe forms of MPS.
The lack of standardized measurement of MCP width,
as well as the lack of normal reference values for this
parameter, was an important limitation. In order to per-
form objective measurement, we used as reference
parameters described in a previous study conducted in
patients with Parkinson disease and multiple system atro-
phy, since it was the only publication we have found con-
taining a description for MCP measurement in MR
images.16 We are aware that additional studies with
FIGURE 6 Sagittal T1-weighted volumetric acquisition demonstrating different cerebellar volumes. A, Normal cerebellar volume in a
30-year-old woman with MPS I Scheie. B, Atrophic cerebellum in a 10-year-old boy with MPS IIIC, characterized by enlargement of
cerebellar sulci. C, Hypoplastic cerebellum in a 7-year-old boy with MPS IIA, defined as cerebellum of reduced dimensions, but preserved
morphology. D, Apparent macrocerebellum in a 4-year-old boy with MPS I Hurler, showing reduction of pericerebellar CSF spaces. CSF,
cerebrospinal fluid; MPS, mucopolysaccharidoses




J-shaped posterior fossa n = 22
Patients without inverted
J-shaped posterior fossa n = 25 P value
Enlargement of CSF spaces present (n) 16 (73%) 10 (40%) .02
Apparent macrocerebellum (n) 12 (54%) 6 (24%) .03
Abbreviations: CSF, cerebrospinal fluid spaces; n, number of individuals.
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age-matched controls are essential for correct interpreta-
tion of the values measured. Although not significant,
neuronopathic MPS patients showed a slight tendency to
thinner MCPs. Considering the fact that MCPs are the
main cerebellar afferent pathway, it may have some rela-
tionship with severe cortical atrophy usually present in
this group.5 It is an interesting potential finding for
future investigations.
In a considerable part of the patients, we observed a
pattern: a depression of the posterior fossa floor in the
midline sagittal plane, which we termed the “inverted
J-shaped posterior fossa.” This finding was statistical
significantly associated with enlargement of CSF spaces,
and with the presence of apparent macrocerebellum,
which leads us to suppose that it is related to volumetric
modifications. Although they are interesting findings, we
still do not know their clinical significance.
Limitations of this study include the mostly qualitative
nature of our analyses. To mitigate the effect of subjectiv-
ity, all images were evaluated by consensus by two radiolo-
gists. Further quantitative studies with volumetric
evaluation may add important information to the current
literature.17 Another limiting factor is the sample size.
Studies with MPS patients usually have a small sample.
We included 47 patients which is a large cohort compared
to those of previous studies. Nevertheless, the absolute
number of participants is still small, limiting comparisons
among groups and precluding analyses of subgroups.
Overall, our findings are consistent with data avail-
able in the literature, especially those of Alqahtani
et al,12 who described the frequency of posterior fossa
findings in 12 patients with MPS types I and II. Besides
compiling the frequency of previously described imaging
patterns, we observed potential new findings and associa-
tions for future investigations. Quantitative studies with
long-term follow-up could help in the search for these
answers.
The present study included a representative sample of
MPS patients, including types I, II, III, IV, and VI, which
increased the applicability of our results to MPS patients
from other medical institutions.
5 | CONCLUSION
The present study compiled the main posterior fossa find-
ings in MPS patients. Classically described in the sup-
ratentorial compartment, MRI-visible perivascular spaces,
white matter lesions, and enlarged perivascular spaces were
also found in the posterior fossa. However, atrophy, which
commonly affects cerebral hemispheres, was not the most
frequent cerebellar morphology found in our study. More-
over, potential findings for future research were described.
ACKNOWLEDGMENT
We would like to acknowledge the patients and members
of Hospital de Clínicas de Porto Alegre (Brazil).
CONFLICT OF INTEREST
The authors declare no potential conflict of interest.
AUTHOR CONTRIBUTIONS
Conceptualization of the study: Roberta Reichert, Juliano
A. Pérez, Amauri Dalla-Corte, Filippo Pinto e Vairo, Car-
olina F. M. de Souza, Roberto Giugliani, Gustavo
R. Isolan, Marco Antonio Stefani. Investigation and data
collection: Roberta Reichert, Juliano A. Pérez, Amauri
Dalla-Corte, Filippo Pinto e Vairo, Carolina F. M. de
Souza. Data analysis: Roberta Reichert, Juliano A. Pérez,
Amauri Dalla-Corte, Filippo Pinto e Vairo, Carolina
F. M. de Souza, Roberto Giugliani, Gustavo R. Isolan,
Marco Antonio Stefani. Supervision: Roberta Reichert,
Roberto Giugliani, Gustavo R. Isolan, Marco Antonio
Stefani. Original draft writing: Roberta Reichert, Marco
Antonio Stefani. Manuscript review and editing: Roberta
Reichert, Juliano A. Pérez, Amauri Dalla-Corte, Filippo
Pinto e Vairo, Carolina F. M. de Souza, Roberto
Giugliani, Gustavo R. Isolan, Marco Antonio Stefani.
INFORMED CONSENT
All procedures followed were in accordance with the eth-
ical standards of the responsible committee on human
experimentation (institutional and national) and with the
Helsinki Declaration of 1975, as revised in 2000.
Informed consent was obtained from all patients for




1. Muenzer J. Overview of the mucopolysaccharidoses. Rheuma-
tology. 2011;50(suppl 5):v4-v12.
2. Clarke LA. The mucopolysaccharidoses: a success of molecular
medicine. Expert Rev Mol Med. 2008;10:e1.
3. Muenzer J. The mucopolysaccharidoses: a heterogeneous group
of disorders with variable pediatric presentations. J Pediatr. 2004;
144:S27-S34.
4. Vedolin L, Schwartz IV, Komlos M, et al. Brain MRI in muco-
polysaccharidosis: effect of aging and correlation with bio-
chemical findings. Neurology. 2007;69:917-924.
5. Reichert R, Campos LG, Vairo F, et al. Neuroimaging findings
in patients with mucopolysaccharidosis: what you really need
to know. Radiographics. 2016;36:1448-1462.
6. Zafeiriou DI, Batzios SP. Brain and spinal MR imaging findings in
mucopolysaccharidoses: a review. Am J Neuroradiol. 2013;34:5-13.
7. Rasalkar DD, Chu WC, Hui J, Chu CM, Paunipagar BK, Li CK.
Pictorial review of mucopolysaccharidosis with emphasis on
MRI features of brain and spine. Br J Radiol. 2011;84:469-477.
40 REICHERT ET AL.
8. Vedolin L, Schwartz IV, Komlos M, et al. Correlation of MR
imaging and MR spectroscopy findings with cognitive impair-
ment in mucopolysaccharidosis II. Am J Neuroradiol. 2007;28:
1029-1033.
9. Mollmann C, Lampe CG, Muller-Forell W, et al. Develop-
ment of a scoring system to evaluate the severity of
craniocervical spinal cord compression in patients with
mucopolysaccharidosis IVA (Morquio A syndrome). JIMD
Rep. 2013;11:65-72.
10. Solanki GA, Martin KW, Theroux MC, et al. Spinal involve-
ment in mucopolysaccharidosis IVA (Morquio-Brailsford or
Morquio A syndrome): presentation, diagnosis and manage-
ment. J Inherit Metab Dis. 2013;36:339-355.
11. Bulut E, Pektas E, Sivri HS, Bilginer B, Umaroglu MM,
Ozgen B. Evaluation of spinal involvement in children with
mucopolysaccharidosis VI: the role of MRI. Br J Radiol. 2018;
91:20170744.
12. Alqahtani E, Huisman TA, Boltshauser E, et al.
Mucopolysaccharidoses type I and II: new neuroimaging find-
ings in the cerebellum. Eur J Paediatr Neurol. 2014;18:211-217.
13. Lee C, Dineen TE, Brack M, Kirsch JE, Runge VM. The
mucopolysaccharidoses: characterization by cranial MR imag-
ing. Am J Neuroradiol. 1993;14:1285-1292.
14. Seto T, Kono K, Morimoto K, et al. Brain magnetic reso-
nance imaging in 23 patients with mucopolysaccharidoses
and the effect of bone marrow transplantation. Ann Neurol.
2001;50:79-92.
15. Manara R, Priante E, Grimaldi M, et al. Brain and spine MRI
features of hunter disease: frequency, natural evolution and
response to therapy. J Inherit Metab Dis. 2011;34:763-780.
16. Nicoletti G, Fera F, Condino F, et al. MR imaging of middle
cerebellar peduncle width: differentiation of multiple system
atrophy from Parkinson disease. Radiology. 2006;239:825-830.
17. Nestrasil I, Vedolin L. Quantitative neuroimaging in mucopoly-
saccharidoses clinical trials.Mol Genet Metab. 2017;122S:17-24.
How to cite this article: Reichert R, Pérez JA,
Dalla-Corte A, et al. Magnetic resonance imaging
findings of the posterior fossa in 47 patients with
mucopolysaccharidoses: A cross-sectional analysis.
JIMD Reports. 2021;60:32–41. https://doi.org/10.
1002/jmd2.12212
REICHERT ET AL. 41
